{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T23:03:50Z","timestamp":1776639830720,"version":"3.51.2"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T00:00:00Z","timestamp":1480377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001545","name":"Children\u2019s Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s11060-016-2314-7","type":"journal-article","created":{"date-parts":[[2016,11,29]],"date-time":"2016-11-29T05:19:46Z","timestamp":1480396786000},"page":"413-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis"],"prefix":"10.1007","volume":"131","author":[{"given":"Mojtaba","family":"Talaei-Khoei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Riklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa L.","family":"Merker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica R.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin T.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-6488","authenticated-orcid":false,"given":"Ana-Maria","family":"Vranceanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"issue":"7 Suppl 1","key":"2314_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.0000000000002927","volume":"87","author":"PL Wolters","year":"2016","unstructured":"Wolters PL, Martin S, Merker VL et al (2016) Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials. Neurology 87(7 Suppl 1):S4\u2013S12","journal-title":"Neurology"},{"issue":"5","key":"2314_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00415-014-7303-1","volume":"261","author":"RE Ferner","year":"2014","unstructured":"Ferner RE, Shaw A, Evans DG et al (2014) Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. J Neurol 261(5):963\u2013969","journal-title":"J Neurol"},{"issue":"4","key":"2314_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0194599815573002","volume":"153","author":"MK Cosetti","year":"2015","unstructured":"Cosetti MK, Golfinos JG, Roland JT Jr. (2015) Quality of life (QoL) assessment in patients with neurofibromatosis type 2 (NF2). Otolaryngol Head Neck Surg 153(4):599\u2013605","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"2314_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1017\/S0022215110000460","volume":"124","author":"WJ Neary","year":"2010","unstructured":"Neary WJ, Hillier VF, Flute T, Stephens D, Ramsden RT, Evans DG (2010) Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2. J Laryngol Otol 124(7):720\u2013728","journal-title":"J Laryngol Otol"},{"issue":"11","key":"2314_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archderm.137.11.1421","volume":"137","author":"P Wolkenstein","year":"2001","unstructured":"Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A (2001) Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 137(11):1421\u20131425","journal-title":"Arch Dermatol"},{"key":"2314_CR6","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ajmg.a.31422","volume":"140A","author":"PZ Page","year":"2006","unstructured":"Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P (2006) Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases. Am J Med Genet A 140A:1893\u20131898","journal-title":"Am J Med Genet A"},{"issue":"6","key":"2314_CR7","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/ajmg.a.36466","volume":"164","author":"VL Merker","year":"2014","unstructured":"Merker VL, Bredella MA, Cai W et al (2014) Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis. Am J Med Genet A 164(6):1431\u20131437","journal-title":"Am J Med Genet A"},{"issue":"3","key":"2314_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11060-013-1195-2","volume":"114","author":"AM Vranceanu","year":"2013","unstructured":"Vranceanu AM, Merker VL, Park E, Plotkin SR (2013) Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol 114(3):257\u2013262","journal-title":"J Neurooncol"},{"issue":"12","key":"2314_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/gim.2012.85","volume":"14","author":"DL Wang","year":"2012","unstructured":"Wang DL, Smith KB, Esparza S et al (2012) Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genet Med 14(12):977\u2013982","journal-title":"Genet Med"},{"issue":"1","key":"2314_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11060-014-1522-2","volume":"120","author":"AM Vranceanu","year":"2014","unstructured":"Vranceanu AM, Merker VL, Plotkin SR, Park ER (2014) The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study. J Neurooncol 120(1):103\u2013109","journal-title":"J Neurooncol"},{"issue":"9 Suppl","key":"2314_CR11","first-page":"II66","volume":"38","author":"D Cella","year":"2000","unstructured":"Cella D, Chang CH (2000) A discussion of item response theory and its applications in health status assessment. Med Care 38(9 Suppl):II66\u2013II72","journal-title":"Med Care"},{"issue":"5 Suppl 1","key":"2314_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N et al (2007) The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first 2 years. Med Care 45(5 Suppl 1):S3\u2013S11","journal-title":"Med Care"},{"issue":"11","key":"2314_CR13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jclinepi.2009.11.021","volume":"63","author":"H Liu","year":"2010","unstructured":"Liu H, Cella D, Gershon R et al (2010) Representativeness of the patient-reported outcomes measurement information system internet panel. J Clin Epidemiol 63(11):1169\u20131178","journal-title":"J Clin Epidemiol"},{"issue":"5 Suppl 39","key":"2314_CR14","first-page":"S53","volume":"23","author":"JF Fries","year":"2005","unstructured":"Fries JF, Bruce B, Cella D (2005) The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 23(5 Suppl 39):S53\u2013S57","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"2314_CR15","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3899\/jrheum.090358","volume":"36","author":"JF Fries","year":"2009","unstructured":"Fries JF, Cella D, Rose M, Krishnan E, Bruce B (2009) Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol 36(9):2061\u20132066","journal-title":"J Rheumatol"},{"issue":"9","key":"2314_CR16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s11136-006-0025-9","volume":"15","author":"CE Schwartz","year":"2006","unstructured":"Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM (2006) The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res 15(9):1533\u20131550","journal-title":"Qual Life Res"},{"issue":"1","key":"2314_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/1087054712450749","volume":"19","author":"VF Mautner","year":"2012","unstructured":"Mautner VF, Granstrom S, Leark RA (2012) Impact of ADHD in adults with neurofibromatosis type 1: associated psychological and social problems. J Atten Disord 19(1):35\u201343","journal-title":"J Atten Disord"},{"issue":"10","key":"2314_CR18","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1016\/j.ridd.2013.07.011","volume":"34","author":"NA Pride","year":"2013","unstructured":"Pride NA, Crawford H, Payne JM, North KN (2013) Social functioning in adults with neurofibromatosis type 1. Res Dev Disabil 34(10):3393\u20133399","journal-title":"Res Dev Disabil"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2314-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2314-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2314-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:22:53Z","timestamp":1589700173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2314-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2314"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2314-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]},"assertion":[{"value":"16 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mojtaba Talaei-Khoei, Eric Riklin, Monica R. Sheridan and Justin T. Jordan report no disclosures. Vanessa L. Merker receives research support from the Program in Cancer Outcomes Research Training (NCIR25CA92203) and a Young Investigator Award from the Children\u2019s Tumor Foundation. Scott R. Plotkin receives research support from the Children\u2019s Tumor Foundation, NIH, and Department of Defense Neurofibromatosis Clinical Trials Consortium. Ana-Maria Vranceanu receives research support from the Children\u2019s Tumor Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}